SBUX
45
5
NRG
44
7
AIV
39
-2
GME
72
-3
JBHT
63
3
FOX
64
2
EXR
24
-4
HAS
66
2
EOG
36
-9
LMT
55
-4
FDX
61
11
PSX
35
-4
PVH
30
-2
DHI
41
9
DLTR
62
-4
AVY
54
-7
MAC
67
2
HRB
42
-2
PAYX
32
-4
AMT
25
-5
SBUX
45
5
NRG
44
7
AIV
39
-2
GME
72
-3
JBHT
63
3
FOX
64
2
EXR
24
-4
HAS
66
2
EOG
36
-9
LMT
55
-4
FDX
61
11
PSX
35
-4
PVH
30
-2
DHI
41
9
DLTR
62
-4
AVY
54
-7
MAC
67
2
HRB
42
-2
PAYX
32
-4
AMT
25
-5
Financhill
Back

Rayliant Quantitative Developed Market Equity ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
43

RAYD
Rayliant Quantitative Developed Market Equity ETF

Last Price:
$37.55
Seasonality Move:
3.83%
Sell
45

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$83.03
Seasonality Move:
-32.16%
Sell
43
Rayliant Quantitative Developed Market Equity ETF (RAYD) is a Sell

Is Rayliant Quantitative Developed Market Equity ETF a Buy, Sell or Hold?

  • The current Rayliant Quantitative Developed Market Equity ETF [RAYD] share price is $37.80. The Score for RAYD is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RAYD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Bright Minds Biosciences, Inc. (DRUG) is a Sell

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $78.88. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RAYD Stock Price Chart

What is Rayliant Quantitative Developed Market Equity ETF's stock price today?

  • The Rayliant Quantitative Developed Market Equity ETF share price today is $37.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAYD is experiencing slight buying pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $78.88
    The current trend is moderately bullish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.

RAYD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.34 Buy
Relative Strength Index (14 RSI): 51.13 Buy
Chaikin Money Flow: 996 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.91 - 38.17) Buy
Bollinger Bands (100): (36.74 - 37.94) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.94 Buy
Relative Strength Index (14 RSI): 54.75 Buy
Chaikin Money Flow: -145421 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60.39 - 83.51) Buy
Bollinger Bands (100): (41.65 - 69.37) Buy

RAYD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.11 Sell
20-day SMA: 37.6 Buy
50-day SMA: 37.58 Buy
200-day SMA: 35.6 Buy
8-day EMA: 14.92 Buy
20-day EMA: 6.85 Buy
50-day EMA: 2.9 Buy
200-day EMA: 0.75 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.2 Sell
20-day SMA: 75.43 Buy
50-day SMA: 66.05 Buy
200-day SMA: 43.03 Buy
8-day EMA: 83.79 Sell
20-day EMA: 77.26 Buy
50-day EMA: 67.4 Buy
200-day EMA: 47.62 Buy

Rayliant Quantitative Developed Market Equity ETF Earnings Growth & RAYD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

Rayliant Quantitative Developed Market Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):